SPAIN - Ysios hires fourth partner

Sanfeliu's professional expertise is financial assessment, mergers and acquisitions, entrepreneurship advice and intellectual property. He started at law firm Cuatrecasas as advisor in M&A and venture capital deals, as well as in the intellectual property area. He later joined KPMG and Eurohold Corporate Finance with special focus on venture capital in the innovation space. The other partners at the Barcelona-based firm are Joël Jean-Mairet, formerly of Glycart Biotechnology; Julia Salaverría, who joined from private equity firm Talde and Cristina Garmendia, who will join the company in future. Garmendia is the president of Inbiomed Foundation, a non-profit research centre focused on technology transfer and research services in the field of regenerative medicine, and is a member of the Advisory Committee of Barcelona's Blood and Tissue Bank. Ysios Capital Partners is one of the first independent venture capital firms in Spain providing private equity financing to early- and mid-stage human healthcare and biotechnology companies. The firm has recently closed its first operation, by co-leading a EUR 27.2m financing round of biopharma business Cellerix, which was led by Life Science Partners and Ventech last month.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• Southern Europe
• Healthcare